Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
Pashenkov M, Goëss G, Wagner C, Hörmann M, Jandl T, Moser A, Britten CM, Smolle J, Koller S, Mauch C, Tantcheva-Poor I, Grabbe S, Loquai C, Esser S, Franckson T, Schneeberger A, Haarmann C, Krieg AM, Stingl G, Wagner SN.
Pashenkov M, et al. Among authors: grabbe s.
J Clin Oncol. 2006 Dec 20;24(36):5716-24. doi: 10.1200/JCO.2006.07.9129.
J Clin Oncol. 2006.
PMID: 17179105
Clinical Trial.